Clinical Trial Update: Post Prandial Glucose Control Proof-of-Principle [Phase 2, Phase 3]

View source ↗

Summary

Abbott Nutrition completed Phase 2 and Phase 3 trials evaluating a product for post-prandial glucose control in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Abbott Nutrition postprandial glucose control product

Snippet

Sponsor: Abbott Nutrition | Conditions: Diabetes Mellitus, Type 2 | Phase 2, Phase 3 | Status: COMPLETED